Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu-Lin Ma

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Nature Communications|February 8, 2020
Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombusXiang-Ming Wang, Yang Lu, Yi-Meng Song, et al.
BMC Urology|March 29, 2018
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyLe-Ye He, Ming Zhang, Zhi-Wen Chen, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Nature Communications|February 8, 2020
Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombusXiang-Ming Wang, Yang Lu, Yi-Meng Song, et al.
BMC Urology|March 29, 2018
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyLe-Ye He, Ming Zhang, Zhi-Wen Chen, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 11